Our investigation revealed that RGS16 overexpression significantly augmented tumor burden (Supplementary Fig. 4A–C), whereas RGS16 knockdown markedly curtailed tumor growth in vivo (Fig. 5A–C). The gene discussed is RGS16; the disease is neoplasm.